Heron Therapeutics, Inc. (HRTX) Social Stream
HERON THERAPEUTICS INC (HRTX) Price Targets From Analysts
Use the tables below to see what analysts covering HERON THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 3 | $60 | $23 | $33 | $1.32 | 2400% |
| 2022-03-01 | 4 | $60 | $18 | $30.8 | $1.32 | 2233.33% |
| 2022-03-02 | 4 | $60 | $13 | $27.2 | $1.32 | 1960.61% |
| 2022-05-10 | 4 | $60 | $12 | $22.8 | $1.32 | 1627.27% |
| 2022-05-11 | 4 | $60 | $7.5 | $21.7 | $1.32 | 1543.94% |
| 2022-08-09 | 5 | $60 | $7.5 | $18.75 | $1.32 | 1320.45% |
| 2022-09-20 | 5 | $14 | $5.5 | $10.1 | $1.32 | 665.15% |
| 2022-11-09 | 5 | $13 | $5.5 | $9.5 | $1.32 | 619.7% |
| 2023-01-19 | 5 | $13 | $5.5 | $9.1 | $1.32 | 589.39% |
| 2023-03-27 | 5 | $13 | $5.5 | $9.1 | $1.32 | 589.39% |
| 2023-05-15 | 5 | $9 | $5.5 | $6.875 | $1.32 | 420.83% |
| 2023-07-10 | 5 | $10.001 | $5.5 | $7.5 | $1.32 | 468.18% |
| 2023-07-24 | 5 | $10 | $5.5 | $7.5 | $1.32 | 468.18% |
| 2023-08-16 | 5 | $10 | $5 | $7.3 | $1.32 | 453.03% |
| 2023-11-15 | 5 | $9 | $5 | $6.625 | $1.32 | 401.89% |
| 2023-11-16 | 5 | $9 | $2.5 | $5.625 | $1.32 | 326.14% |
The Trend in the Analyst Price Target
Over the past 42 months, HRTX's average price target has gone down $32.67.
Over the past 43 weeks, HRTX's average upside potential has been 392.51%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-19 | 4 | 13.000 | 5.5 | 9.1 | 2.95 | 208.47% |
| 2023-05-11 | 5 | 10.000 | 5.5 | 7.7 | 2.23 | 245.29% |
| 2023-05-15 | 5 | 10.000 | 5.5 | 7.7 | 1.33 | 478.95% |
| 2023-07-10 | 5 | 10.001 | 5.5 | 7.5 | 1.30 | 476.92% |
| 2023-08-16 | 5 | 10.000 | 5.0 | 7.3 | 1.63 | 347.85% |
HRTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 43 months, HRTX's average broker recommendation rating worsened by 0.2.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HRTX as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, HERON THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1702.7% of them.
- HRTX has a lower variance in analysts' estimates than -1406.57% of all US stocks.
- In the context of stocks in the mid market cap category, HERON THERAPEUTICS INC's number of analysts covering the stock is higher than 318.78% of them.
- HERON THERAPEUTICS INC's average analyst price target is higher than 350.9% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HERON THERAPEUTICS INC are ADCT, AMTI, and CERE.
View All Top Stocks by Price Target
What is the outlook for HRTX? Use POWR Ratings for clearer insight into price direction.